Drugs Made In America Acquisition Corp. Ordinary SharesDMAA

$10.63+0.01 (+0.09%)
NASDAQFinancial Services24:00 UTC

Company snapshot

Market Cap
$244M
Micro-cap
+186%
2025 — today
10-Year Price
+6%
2025 — today
52-Week Range
$10.18$10.63
Current $10.63· 100%

Drugs Made In America Acquisition Corp. functions as a special purpose acquisition company, commonly known as a blank check company. Its core mission is to seek out and ultimately acquire one or more existing businesses or their assets. This acquisition strategy encompasses a variety of transactional methods, such as corporate mergers, capital stock exchanges, direct asset purchases, stock acquisitions, or broader corporate reorganizations.

Valuation in context

P/E ratio
52.0
Near historic high
Near historic highs — last 10 years
P/B ratio
1.0
Above average
Pricier than usual over the last 10 years
FCF Yield
-0.2%
Historically high
Historically high relative to the last 10 years
Free · No credit card needed

Get alerted when DMAA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.